Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes

MLA

Debra Wu, et al. “Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes.” Pharmaceutics, vol. 13, no. 1, Jan. 2021, p. 107. EBSCOhost, https://doi.org/10.3390/pharmaceutics13010107.

APA

Debra Wu, Douglas Vogus, Vinu Krishnan, Marta Broto, Anusha Pusuluri, Zongmin Zhao, Neha Kapate, & Samir Mitragotri. (2021). Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes. Pharmaceutics, 13(1), 107. https://doi.org/10.3390/pharmaceutics13010107

Chicago

Debra Wu, Douglas Vogus, Vinu Krishnan, Marta Broto, Anusha Pusuluri, Zongmin Zhao, Neha Kapate, and Samir Mitragotri. 2021. “Optimized 5-Fluorouridine Prodrug for Co-Loading with Doxorubicin in Clinically Relevant Liposomes.” Pharmaceutics 13 (1): 107. doi:10.3390/pharmaceutics13010107.